Home・Aandelen Lijst・Pharma Mar SA

P
Pharma Mar SA

Open

79.1 0.76

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

78.4

Max

80.1

Belangrijke statistieken
By Trading Economics
Inkomsten	-58M 1.6M
Verkoop	-48M 43M
K/W Sectorgemiddelde	17.175 64.641
EPS	0.088
Winstmarge	3.725
Werknemers	505
EBITDA	-40M 2.7M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+27.63% upside

Dividenden
By Acuity
Volgende Winsten	29 okt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-280M 1.4B
Vorige openingsprijs	78.34
Vorige sluitingsprijs	79.1

Pharma Mar SA Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

3 aug 2026, 23:56 UTC

Full Truck Alliance Co Ltd. is trading higher in after-market hours, reflecting routine fluctuations within a narrow range above its 20-day moving average.

3 aug 2026, 23:56 UTC

State Street Corp shares are trading lower in after-market hours, following a modest decline after Monday's regular session close.

3 aug 2026, 23:56 UTC

Pentair PLC shares are lower in after-market hours with no specific news driving the decline. The stock remains within its one-month trading range.

3 aug 2026, 23:56 UTC

News

Diversified Healthcare Trust reported second-quarter FFO of $0.16, exceeding estimates. Revenue fell short at $365.39 million, contributing to a decline in after-market trading.

3 aug 2026, 23:56 UTC

Correlated Moves

Masco Corp shares are higher in after-market trading, supported by a notable rise in JELD-WEN Holding Inc. The stock remains near its one-month range low.

3 aug 2026, 23:56 UTC

Stanley Black & Decker shares are higher in after-market trading, supported by positive market sentiment and easing inflation concerns amid declining oil prices.

3 aug 2026, 23:56 UTC

Correlated Moves

Microstrategy Inc shares declined after market hours, reaching a low of -1.10%. The drop may be influenced by Bitcoin's recent decline.

3 aug 2026, 23:56 UTC

Chewy Inc. shares are trading higher in after-market hours, rebounding from a brief dip following Monday's close amid broader positive market sentiment.

3 aug 2026, 23:56 UTC

Kroger Co shares are lower in after-market trading, retracing from an earlier rise and settling around the midpoint of their one-month trading range.

3 aug 2026, 23:56 UTC

MGM Resorts International shares are higher in after-market hours, continuing modest gains since Monday's close amid positive sentiment in European markets.

3 aug 2026, 23:56 UTC

Equinix Inc shares are higher in after-market hours, reflecting broader market strength amid gains in European indices and falling oil prices.

3 aug 2026, 23:56 UTC

Correlated Moves

Martin Marietta Materials shares are higher in after-market trading, supported by positive market sentiment and correlated gains in nVent Electric PLC.

3 aug 2026, 23:56 UTC

Incyte Corp shares are higher in after-market hours, recovering from five consecutive daily declines. Broader market sentiment remains positive amid declining oil prices.

3 aug 2026, 23:56 UTC

Brown & Brown Inc shares are trading lower in after-market hours, following a session that included an early spike before a steady decline.

3 aug 2026, 23:56 UTC

AutoZone Inc shares are trading higher in after-market hours, recovering from a dip after Monday's close with no specific news identified for the movement.

3 aug 2026, 23:56 UTC

J M Smucker Co shares are higher in after-market hours, recovering from earlier declines and remaining above their 20-day moving average. No specific news was identified.

3 aug 2026, 23:56 UTC

ETF Constituents

The iShares China Large-Cap ETF is trading roughly flat in after-market hours, supported by LI's positive return and JD's slight decline.

3 aug 2026, 23:56 UTC

Correlated Moves

NIO Inc shares are higher in after-market trading, reflecting positive sentiment in the electric vehicle sector. Xpeng Inc also saw a price increase.

3 aug 2026, 23:56 UTC

JPMorgan Chase & Co shares are higher in after-market hours, supported by positive sentiment in European markets. The asset remains above its 20-day moving average.

3 aug 2026, 23:56 UTC

Bath & Body Works Inc. shares declined slightly in after-market trading, reflecting routine fluctuations despite remaining above the 20-day moving average.

3 aug 2026, 23:56 UTC

News

First Solar Inc reported second-quarter revenue of $1.06 billion and a net profit of $423 million. Shares are higher in after-hours trading.

3 aug 2026, 23:56 UTC

Cisco Systems Inc shares are lower in after-market hours, with no specific news identified to explain the decline. The broader market showed mixed signals.

3 aug 2026, 23:56 UTC

Indie Semiconductor Inc. shares are higher in after-market trading, showing modest gains since Monday's close amid positive broader market sentiment.

3 aug 2026, 23:56 UTC

Correlated Moves

Riot Platforms Inc. is higher in after-market hours, recovering from an initial dip. Positive sentiment in European indices supports cryptocurrency-related stocks.

3 aug 2026, 23:56 UTC

Correlated Moves

Kosmos Energy Ltd shares are higher in after-hours trading, reflecting positive sentiment in the energy sector and influenced by Crescent Energy's notable gains.

3 aug 2026, 23:56 UTC

New Fortress Energy Inc shares are higher in after-market trading, reflecting a recovery from earlier lows amid positive sentiment in European markets.

3 aug 2026, 23:56 UTC

Macro News

Crude oil prices are lower as President Trump called off a military strike on Iran, boosting optimism for stability in the Middle East.

3 aug 2026, 23:52 UTC

Social Media

Correlated Moves

News

Microsoft shares are lower in after-market hours amid a class action lawsuit alleging misrepresentation of its Copilot products' performance and competitive position.

3 aug 2026, 23:51 UTC

Schneider National shares higher in after-market trading, reflecting notable strength since Monday's close despite remaining below the 20-day moving average.

3 aug 2026, 23:51 UTC

Shake Shack Inc. shares declined after-market, contrasting with gains in major U.S. tech stocks. The asset remains above its 20-day moving average.

Peer Vergelijking

Prijswijziging

Pharma Mar SA Prognose

Koersdoel

By TipRanks

27.63% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 100.001 EUR 27.63%

Hoogste 100 EUR

Laagste 100 EUR

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Pharma Mar SA - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan Pharma Mar SA - Dist in de afgelopen 3 maanden.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Pharma Mar SA

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments. It develops and commercializes Yondelis for the treatment of soft tissue sarcoma and for ovarian cancer; Aplidin for treating R/R multiple myeloma; and Zepzelca to treat patients with small cell lung cancer. The company develops Ecubectedin (PM14), which is in phase II clinical trials for the treatment of solid tumors, as well as in Phase I clinical trials for the treatment of soft tissue sarcoma and prostate cancer; PM534 that is Phase I clinical trials for treating solid tumors; PM54, which is in Phase I clinical trials for the treatment of solid tumors; SYL1801 that is in phase II clinical trials for treating macular degeneration; SYL116011, which is in preclinical studies for the treatment of ocular allergies; and SYL A and B that is in investigational studies to treat retinitis pigmentosa. In addition, it engages in the research, development, production, and sale of products with therapeutic activity based on reducing or silencing gene expression. Pharma Mar, S.A. was incorporated in 1986 and is based in Madrid, Spain.